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A  neoplastic disease of  the  hematopoietic  system  of mice  which  is  trans- 
missible by cell-free filtrates has been described in a  previous report (1). This 
lethal disorder, first noted in a  Swiss mouse injected ineffectually with a  cell- 
free preparation of the Ehrlich carcinoma, has the character of a  leukemia and 
is serially and regularly transmissible to both Swiss and DBA/2 adult mice by 
an agent present in cell-free filtrates prepared from the neoplastic tissue. 
Antisera capable of neutralizing the agent have now been produced in mice 
and rabbits, and the effect on the agent of various normal sera and those from 
mice with  other  neoplasms,  including leukemia,  have also  been  subjected  to 
inquiry.  An  active  immunity  to  the  leukemic  effects  of  the  virus  has  been 
regularly induced in mice by a  vaccine prepared by treating filtered extracts of 
the neoplastic tissues with formalin. These results are here reported. 
Materials and Methods 
Animals.--Adult  mice of Swiss breed weighing 16 to 19 gin. were used throughout. 
Antigen.--The greatly enlarged  spleens of Swiss mice with leukemia as a result of inocu- 
lation with the agent 21 to 35 days before were ground in a TenBroeck  homogenizer. A 20 
per cent suspension was made with Locke-Ringer's solution, 1 and this was centrifuged  for 10 
minutes at  1,000 a.p.xf, to remove  coarse particles. The supematant fluid contained whole 
cells in substantial numbers.  In some instances,  it was  employed  as the antigen without 
further  treatment, and  in others,  after passage  through  a  Selas 03  filter impermeable to 
Escherichia coli. 
A~a/sera.--Four rabbits weighing 4 to 5 kilos were immunized.  Two were inoculated with 
filtrates and two with cell suspensions of leukemic spleens. A course of four intrapefitoneal 
injections of 5 cc. each was given at 3-day intervals. The rabbits were bled 14 to 21 days 
after the last injection, and the sera thus obtained were tested individually. 
* This work was supported in part by a  research grant from the National Cancer Insti- 
tute, National Institutes of Health of the United States Public Health Service, and in part 
by the Phoebe Waterman Foundation. 
1 Locke-Ringer's solution,  buffered at pH 7.2, contained 6 rag. of glucose per ml., 50 # 
of penicillin per ml., and 2 mg. of streptomycin per ml. 
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In addition, 50 Swiss mice, weighing 25  to 28 gm., were bled. Their sera were collected 
between 30 and 60 days after two or three intraperitoneal injections of 0.2 cc. each of filtrate 
given at 2-week intervals. These sera were pooled. 
All sera were stored in sealed ampoules at 4°C. with no preservative added. 
Neutralization  Tests.--All  sera were inactivated in a  water bath at 56°C. for 30 minutes. 
Undiluted serum was mixed in equal amount with either a  freshly prepared 20 per cent sus- 
pension of the tissue of leukemic spleens or the filtrate from such material. After incubation 
in a  water bath at 37°C. for 90 mniutes, 0.2  cc, of the mixture was injected i.p. into each 
test mouse. 
Vaccination.--Enough  formalin was  added  to  filtrates of  10  or  20 per cent extracts  of 
infected spleens to  give a  final concentration of 1:500.  The  mixture was kept at  4°C.  for 
21  days  and  shaken manually  each  day  throughout  this period prior to  use.  It  was  then 
TABLE  I 
Resistance  of Mice to Reinoculation  with the Agent 
Original  Challenged 
inoculum*  with$ 
Cells  Cells 
Cells  Filtrate 
Filtrate  Cells 
Filtrate  Filtrate 
Time of challenge (mos. after 1st inoculation) 
6  8  10 
1---2/14  1/12--0/--6  ---- 
5/5  I  4/5  I  5/5  I  -- 
Total 
5/5 
1/5 
5/5 
2/23 
5/5 
0/4 
5/5 
o/3 
5/5 
o/3 
5/5 
4/12 
5/5 
o/10 
5/5 
6/25 
5/5 
0/3 
5/5 
N_o.  positr__,  iy_ee 
93.3 
1/9 
lO/lO 
12/63 
20/20 
0/16 
15/15 
Per  cent 
positive 
11.0 
100 
19 
100 
0 
100 
* 0.2 ml.  10 per cent dilution, intraperitoneal. 
0.2  "  20 per cent  "  ,  " 
tested as a  vaccine. Three i.p. injections were given at weekly intervals to mice weighing 16 
to 19 gm. prior to challenge with active material at times indicated in the text. 
RESULTS 
When  cell-free  material  was  first proven to be  effective  in  inducing  the 
disease,  approximately 20 per  cent of the mice injected with whole ceils or 
filtrate remained  healthy  (1).  These survivors, which  had never shown  any 
signs of leukemia, were subsequently found immune to a challenge injection of 
leukemic material  that  caused the  disease  in most  of the untreated control 
mice. This proved to be the case even when months had elapsed between the 
original and the challenge inoculations (Table I). 
As can be seen, most of the mice which had survived the original injection 
failed to develop leukemia when reinjected with another disease-producing, cell- c.  FRIEN-O  219 
free filtrate or cell suspension. Of particular interest was the fact that animals 
which had survived injection with filtrate also proved highly resistant on sub- 
sequent inoculation of either filtrate or neoplastic cells. 
Although the results of these experiments indicate that the mice surviving 
reinoculation had  a  manifest resistance as  compared with  the controls,  the 
source of their immunity was not clear. It was necessary to find out whether 
they were innately insusceptible and hence had survived the first as well as the 
second inoculation, or whether the small amount of the agent originally injected 
had been sufficient to cause an immune response but not to induce the disease. 
With this aim, the antigenicity of the agent was investigated. 
Na~ralir, ation Tests.--Neutralization tests were conducted with the antisera 
from mice and rabbits injected with the agent, as described under Methods. 
Sera from the rabbits obtained prior to immunization and sera from normal 
mice served for controls. 
TABLE  II 
Neutralization* of Agent by Specific Mouse Antiserum 
Normal serum  Antiserum 
No. positive  Per cent survivors  No. positive  Per cent survivors 
No. inoculated  No. inoculated 
20/24  16.7  3/30  90 
24/25  4.0  10/25  60 
* Serum mixture incubated  at  37°C.  for  1~  hours before  inoculation  of 0.2  cc.  intra- 
peritoneally. 
The results of testing the pooled serum collected from mice immunized with 
filtrate are given in Table II. Although sera from normal mice, whether from 
strains susceptible or resistant to the agent, do not contain neutralizing anti- 
body, antisera from the treated mice neutralized the agent. 
When the antiserum was mixed with filtrate, 90 per cent of the thirty mice 
survived, as compared with 16 per cent of those that had received normal serum 
plus filtrate. When cells were tested with antiserum, 60 per cent of the mice 
survived as compared to 4 per cent among the normal serum plus cells controls. 
Furthermore, the incubation period of the disease in the mice which did develop 
leukemia from the immune serum-cell mixture was on the average 21  to  28 
days, as compared to 10 to 14 days in the mice given the cells with normal 
serum. 
Antisera  prepared  in  rabbits  gave  similar  results.  The  findings  with  the 
serum  from rabbits  1  and  2,  which  were immunized with  cell-free filtrates, 
appear in Table IIL When the pre-immunization serum of rabbit 1 was mixed 
with  the leukemic spleen cell suspension,  15 per cent of the 45  control mice 220  MOUSE  LEUKEMIA  VIRUS 
survived the inoculation, as compared to 72 per cent of the 44 mice given the 
cells in immune serum. When the normal serum was mixed with filtrate, 14 per 
cent of the 50 mice survived, whereas all of the 51 mice injected with the mix- 
ture of antiserum and filtrate lived. 
None of the mice survived the inoculation of the mixture of cells and the 
control serum of rabbit  2,  whereas  there was a  survival rate of 67  per cent 
among the 18 mice given the cells in the immune serum from the same rabbit. 
When the filtrate was tested, 12 per cent of the 86 control mice lived, as com- 
pared to 95 per cent among the 158 mice given the antiserum-filtrate mixture. 
Essentially  the  same  results  were  obtained  with  the  serum  from rabbits 
immunized with cell-containing infected spleen preparations. This is shown in 
TABLE III 
The Effect of Antiserum from  Rabbits Inoculated with Filtrate on the Infectivity of Leukemic 
Cells or Cell-Free Filtrate 
Cells mixed with normal serum 
No. positive/No, inoculated 
Per cent survival 
Cells mixed with antiserum 
No. positive/No, inoculated 
Per cent survival 
Filtrate mixed with normal serum 
No. positive/No, inoculated 
Per cent survival 
Filtrate mixed with antiserum 
No. positive/No, inoculated 
Per cent survival 
Rabbit 1  Rabbit 2  Total 
38/45 
15.6 
12/44 
72 
18/18 
0 
6/18 
67 
43/50 
14 
0/51 
100 
75/86 
12 
8/158 
95 
56/63 
11 
18/62 
70 
118/135 
13 
8/209 
96 
Table IV. When thenormal  pre-immunization serum of rabbit 3 was mixed with 
cells, 15 per cent of the 20 mice survived, as compared to 60 per cent among 
those inoculated with the immune serum mixture. When the filtrate was used, 
21 per cent of the controls survived, as compared to 100 per cent in the anti- 
serum group. 
When cells were mixed with normal serum from the 4th rabbit, 29 per cent of 
the 59 inoculated mice survived, as compared with 86 per cent among those 
receiving  the  antiserum  mixture.  With  filtrate,  15  per  cent  of  the  controls 
survived, in contrast to 100 per cent of those given filtrate plus antiserum. 
From these data, there appears to be no significant difference in the neutraliz- 
ing capacity between the antisera obtained from rabbits after immunization 
with either cells or filtrate. Whatever differences have been observed may be 
attributed either to the variation of the individual rabbit to produce antibody, c.  Imm~-D  221 
or to the variation in the virulence of the leukemic preparation  used in each 
test, as can be seen by noting the controls in each of the tables. In all instances, 
however, the filtrate was more effectively neutralized than the cell suspensions. 
Further  evidence  indicating  that  neutralization  of  infectivity  is  brought 
TABLE IV 
The E~ed of Antiserum from Rabbits Inoculated with Cell Suspensions on the Infectivity  of 
Leukemic Cdls or Call-Free Filtrate 
ells mixed with normal serum 
No. positive/No, inoculated 
Per cent survival 
ells mixed with antiserum 
No. positive/No, inoculated 
Per cent survival 
~iltrate mixed with normal serum 
No. positive/No, inoculated 
Per cent survival 
~iltrate mixed with antiserum 
No. positive/No, inoculated 
Per cent survival 
Rabbit 3  Rabbit 4  Total 
17/20 
15 
8/20 
60 
15/19 
21 
0/28 
I00 
42/59 
29 
8/59 
86 
17/20 
15 
0/20 
100 
59/79 
25 
16/79 
80 
32/39 
18 
o148 
100 
TABLE V 
The Effect of Untreated and Absorbed Antiserum on the Infectidty of Leukemic Cells 
or Cell-Free Filtrate 
Rabbit serum 
Normal control 
Leukemic 
Anti-filtrate 
Absorbed anti-filtrate 
Anti-cells 
Absorbed anti-cells 
Incubated with cells* 
No. po~ve  Per cent 
No. inoculated  survival 
9/9  0 
4/10  60 
4/9  56 
3/9  67 
3/9  67 
Incubated with filtrate* 
No. positive 
N'o. inoculated 
8/9 
I  0/9 
0/8 
0/9 
I  0/9 
Per cent 
survival 
13 
I00 
I00 
I00 
I00 
* Serum mixtures incubated at 37°C. for 1~ hours before inoculation of 0.2 cc. intraperi- 
toneally. 
about by specific  antiviral  antibody was obtained from studies with absorbed 
antiserum. In one experiment, shown in Table V, each sample of antiserum was 
divided  into  two aliquots.  One was  set  aside  and  the  other  was  extensively 
absorbed with dried normal mouse spleen and serum before testing. As can be 
seen, the absorption procedure did not remove the neutralizing antibody. Such 
treated antiserum was as effective as the unabsorbed. None of the mice inocu- 222  MOUSE  LEUKEMIA  VIRUS 
lated with the cells in normal rabbit serum survived, whereas between 56 and 
67 per cent of the mice injected with the cells in absorbed or untreated anti- 
serum lived. Similarly, only 13 per cent of the mice given the filtrate-normal 
serum survived, as compared to 100 per cent of those injected with the filtrate- 
antiserum mixtures. The antisera prepared against filtrate and against cells are 
listed separately to demonstrate that  each retains the capacity to neutralize 
infectivity after absorption with normal tissue.  It remains to be determined 
whether absorption with leukemic cells will remove neutralizing antibody. This 
experiment is in progress. 
TYPES 
OF 
SERA 
No. 
MICE 
NEUTRALIZA770N OF AGENT  USED 
MOUSE-SPE~IFIC 
~~ANTISERA  30 
~  MOUSE-NORMAL  24 
~//////////////~HUMAN -NORMAL  109 
~//~  HUMAN-LEU KEMIA  i 04 
 usE  LEUKEM,A  41  NON-FILTERABLE 
~/////,/~//,/~,/~  MOUSE LEUKEMIA-AK  25 
~  ,MOUSE  LEUKEMIA  30 
(SCHWARTZ) 
~~J~  MOUSE CARCINOMA  25  ~///3  ERLICH./K,qCITE$ 
w  I  m  I  i  I  i  I  i  I 
20  40  60  80  I00 
PER  CENT SURVIVAL 
Fro. 1 
Neutralization  Tests with Other Sera.--A number of samples of human serum 
were tested for neutralizing power (Fig. 1). Of the normal sera, eight were from 
individual  donors to the Blood Bank of Memorial Hospital and three others 
were pooled sera, kindly sent to us by Dr. Thomas Francis, Jr. A  total of 20 
per cent of the  109  mice inoculated with the mixtures of these sera and our 
leukemia agent survived. Eleven sera from as many leukemic human beings  ~ 
were also studied. Two of the samples were from patients in remission and the 
others  from patients  with  either  acute  or  chronic  leukemia.  There  was  an 
over-all survival rate of 23 per cent of the 104 mice used in these tests, as com- 
The sera from leukemic human beings were received through Drs. R. R. Ellison, L. 
Murphy, and C. Tan of the Leukemia Service of Memorial Hospital. c.  r~E~  223 
pared to 22 per cent among the controls. In other words,  the percentage of 
survivors was about the same as if serum had been absent. 
L1210, C1498, 82T, and 8174 are non-filterable, well established cell-trans- 
missible mouse leukemias.  Sera from mice in  the  early as well as advanced 
stages  of  one  or  another  of  these  cell-transferred  leukemias  contained  no 
neutralizing antibody. The total survival rate of the 41 mice inoculated with 
these serum-agent mixtures was 25 per cent, as compared to 20 per cent for the 
controls. 
The lack of effect of the sera of leukemic AK mice is especially noteworthy. 
Gross and others have reported leukemia induction in newborn mice injected 
with cell-free material from tissues of leukemic mice of this strain (2-4). Hence, 
it was of interest to determine whether an immunologic relationship existed 
between the AK leukemia agent and that of our disease. Only 20 per cent of the 
25 mice inoculated with the sera of leukemic AK mice plus the agent survived, 
indicating that these sera contain no protective antibody against  our agent. 
Further  evidence to  support  this  finding  was  provided by data  not  given 
here  which  show  that  rabbit  antiserum  against  the  rapidly  passaged  AK 
agent  (5)  supplied by Dr.  Ludwik  Gross, and  rabbit antiserum against  the 
Stewart and Eddy tissue-cultured agent (6) supplied by Dr. Sarah Stewart, are 
also lacking in neutralizing antibody. 
Swiss mice bearing yet another leukemia induced by cell-free material  (7) 
were obtained from the laboratory of Dr.  S.  O.  Schwartz. The sera of these 
animals did not neutralize the infectivity of our agent, only 5 of the 30 mice 
• surviving, 
Since our leukemia agent was originally recovered from a mouse which had 
been inoculated in infancy with a  cell-free extract of the Ehflich ascites car- 
cinoma (1), the sera from mice bearing this tumor were also tested for neutraliz- 
ing capacity. None was demonstrable, only 6 of the 25 mice surviving. 
The results with all the sera tested are shown in Fig. 1, in terms of the per 
cent survival of mice inoculated with each of the various serum-filtrate mix- 
tures. These are compared with the survival rate of 16 per cent among the 24 
control mice which had received normal mouse serum plus the agent and of 90 
per cent among the 30 mice which were injected with the specific antiserum- 
agent  mixture.  From  the  data  it  would  appear  that  there is  no direct  im- 
munological relationship  between  any  of the  sera  tested  and  our leukemia 
agent of Swiss mice. 
Vaccination against the Agent.--Since  the  filtrate  of  leukemic  tissue  was 
capable of inducing a good neutralizing antibody response in rabbits and mice, 
the possibility of preparing a  vaccine from the agent which would induce a 
specific active immunity was investigated. One hundred mice were immunized 
with a formalin-treated filtrate. Each received three intraperitoneal injections 
of 0.3  cc. each, given at weekly intervals, as describe under Methods. On the 224  MOUSE LEUKEMIA  VIRUS 
7th, 14th, 21st, and 28th days after the last injection, 25 of the treated mice 
were challenged by an intraperitoneal injection of 0.2  cc.  of a  20 per  cent 
filtrate of leukemic spleens. An equal number of normal animals of the same age 
and sex had been set aside at the beginning of each experiment to serve as 
controls for the  challenge inoculation given the vaccinated group. 
The results of these four experiments are presented in Fig. 2. Among the mice 
challenged 7 days after the last vaccine injection 80 per cent survived, as con- 
trasted with 14 per cent among an equal number of the control mice. At 14 
8( 
6(: 
PERCENT 
.SURVIVAL 
4( 
2C 
0 
t1" 25  MICE  PER  GROUP 
SURVIV,4L RArE OF CONTROL AND  VACCINATED MICE ~ 
In'rfl CONTROL  L~,~. VACCINATED 
7  14  21  28 
DAY OF  POST  VACCINATION  CHALLENGE 
FIG. 2 
days after, 82 per cent of the immunized animals lived, as compared with 14 per 
cent of the controls. After 21 days, 79 per cent of the mice in the vaccinated 
group and 25 per cent of the controls survived; and of those tested after 28 
days, 78 per cent survived, as compared with 23 per cent of the controls. 
Vaccination  with  formalinized filtrates  also  prevented  leukemia  in  mice 
inoculated with whole leukemic ceils. Of 30 immunized mice, only 7 came down 
with the disease after intraperitoneal challenge with a 20 per cent cell suspension 
from leukemic spleens, whereas 79 per cent (19 mice) of the 24 unvaccinated 
controls developed it. 
Effect of Immunization on Other Mouse Neoplasms.--Since a strong immunity c.  ~Em)  225 
against the leukemia was obtained by means of the vaccine, it was decided to 
test its protective capacity against a number of other mouse neoplasms. 
Leukemias C1498 in C67B1/6 mice, 82T in Fl(Css X  BALB) mice, and L1210 
in DBA/2 mice, and also the Ehrlich ascites carcinoma in Swiss mice, were 
selected for test. Adult C57B1/6 and the F1 mice were injected with freshly 
prepared 20 per cent suspensions of leukemic spleen, since these mice are not 
susceptible to the agent (1). The DBA/2 and Swiss mice were vaccinated with 
formalin-inactivated filtrates.  Three  intraperitoneal  inoculations  of  0.3  cc. 
each were given per group. Fourteen days after the last of the injections, the 
mice received the test material. 
Although specific neutralizing antibody against our agent could be demon- 
strated in the sera of the immunized animals, no protection was evident against 
the other lines of transplantable leukemia, nor were they altered in their course 
TABLE VI 
The Effect of Vaccination against Other Mouse Neoplasms 
Neoplasm 
'1498 
2 T 
1210 
;hrlich (SC) 
Mouse strain 
C57 B1/6 
FI(C~ X  BALB) 
DBA/2 
Swiss 
Control 
No. positive 
No. inoculated 
20/20 
10/10 
8/8 
7/10 
Immunized 
No. positive 
No. in~u~t~ 
20/20* 
10/I0" 
8/8t 
8/10t 
* Vaccinated  with viable material. 
Vacdnated with formalinized material. 
(Table VI). Both control and immunized mice died of the test leukemias. In the 
groups with the Ehrlich ascites tumor the number of cells implanted (200,000 
cells, one-fifth of the usual dose) was so small that survivors had been expected. 
Among the controls 70 per cent developed tumors, as compared with 80 per cent 
of  the  immunized mice.  When vaccinated mice were  injected with 500,000 
cells  intraperitoneally,  there  were  no  survivors  either  among  them  or  the 
controls. 
Effect of Immunization with Other Cell-Free Leukemic  Agents.--Although  it 
was known that the sera from AK leukemic mice did not neutralize  the in- 
fectivity of our agent, it seemed of interest to determine whether  active im- 
munization with the AK agent would have some effect. 
Two groups of 20 Swiss mice each were injected---one with cells,  and the 
other with filtrates of a potent AK leukemia suspension.  3 Two intraperitoneal 
s The AK preparation  kindly provided  by Dr.  George Woolley of the Sloan-Kettering 
Institute was active in inducing leukemia and  parotid  gland tumors when inoculated into 
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injections of 0.2 cc. each were given at 3-day intervals to each group. A third 
group of ten mice was set aside for controls. Ten days after the last injection the 
mice of all three groups were challenged intraperitoneally with 0.2 cc. of a  20 
per cent filtrate containing our agent. There was no difference in the results with 
the control and "immunized" groups. Eighty per cent in each case developed 
the disease. 
A similar experiment was set up with 16 mice that had survived inoculation 
with the leukemia of Schoolman et al.  (7). Eighty-three per cent of these mice 
died of leukemia after being challenged with  our agent,  a  figure essentially 
similar to that for our control animals. 
DISCUSSION 
There have been recent reports  on the immunological aspects of two other 
leukemia agents.  Dulaney eta/.  (8) found that  sera  prepared by treating  either 
mice or rabbits  with the AK leukemia agent did not contain neutralizing  anti- 
body for the agent. When the mixtures of anti-sernm and AK extract were 
inoculated into AKR or C~-I/Hf mice, there was no significant difference in the 
onset of leukemia between the control and experimental groups. In addition, old 
mice which had received one or more injections of the AK agent when newborn 
and had remained apparently healthy came down with leukemia after receiving 
small amounts of AK leukemic cells. 
In  contrast,  Grafli et  al.  (9)  reported a  significantly lower percentage of 
of leukemia developing in newborn mice inoculated with the leukemia agent 
they obtained from Sarcoma I  (Sa I), mixed with rabbit  antiserum against 
cell-free extracts of the Sa I, than in the controls which had received the agent, 
either alone or mixed with normal rabbit serum. It was not possible, however, to 
detect neutralizing antibody in the sera of mice after immunization with Sa I 
filtrates "attenuated" by heat or formaldehyde. Thus, neither the AK nor Sa I 
leukemia agents appear to be antigenic in their natural host, the mouse. 
In contrast to the findings obtained with the AK and Sa I  agents, the leu- 
kemia agent of Swiss mice has been shown to evoke so good a specific antiviral 
response in both mice and rabbits as to make the production of a prophylactic 
vaccine feasible. 
Specific  antibody  neutralized  the  infectivity  of  both  cells  and  cell-free 
preparations of infected spleens, although neutralization of the cells was not as 
complete as that  of the filtrate. A  similar phenomenon was  observed in the 
protection of immunized mice against  challenge with  cellular suspensions of 
leukemic spleen. In the light of the studies of Rouset al.  (10) on the failure of 
immune sera to affect living cells of the Shope fibroma of rabbits, it is difficult 
to reconcile this apparent effect of antibody on virus-containing leukemic cells. 
Further studies are being made to determine whether the cells were viable, for it c.  Fm-E1~ro  227 
seems possible that they are so fragile as to have been injured by the grinding 
prior to suspension, and therefore had allowed the entry of antibody. 
Work is in progress to define the duration  of the immunity resulting from 
vaccination and the effectiveness of a vaccine formalinized for a shorter period of 
time. The effect of the vaccine given at closer intervals, for instance at 3-day 
instead of the present 1-week intervals, is also being investigated. 
SUMMARY 
The antigenic character of a filterable agent which induces leukemia in adult 
mice has been investigated. Mice and rabbits injected with filtrate yielded sera 
which specifically neutralized infectivity of the agent. Normal sera, sera from 
mice with other neoplasms--including leukemias from which no causative agent 
has as yet been obtained,--and sera from leukemic human beings contained no 
such neutralizing antibody. A  formalinized vaccine prepared from filtrates of 
leukemic spleens induced a  significant degree of immunity against the agent, 
approximately 80 per cent of the vaccinated mice being immune on challenge 
with it. 
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